S'abonner

Predicting episodes of poor asthma control in treated patients with asthma - 20/08/11

Doi : 10.1016/j.jaci.2006.09.006 
Karen McCoy, MD a, David M. Shade, JD b, , Charles G. Irvin, PhD c, John G. Mastronarde, MD a, Nicola A. Hanania, MD d, Mario Castro, MD, MPH e, N.R. Anthonisen, MD, PhD f

for the American Lung Association Asthma Clinical Research Centers

  Participating centers listed in Appendix B.

a From the Ohio State University 
b Johns Hopkins University, Baltimore 
c University of Vermont 
d Baylor College of Medicine, Houston 
e Washington University School of Medicine, St Louis 
f University of Manitoba 

Reprint requests: David M. Shade, JD, Johns Hopkins School of Public Health, Center for Clinical Trials, 615 N Wolfe Street, Room 5025-D, Baltimore, MD 21205.

Columbus, Ohio, Baltimore, Md, Burlington, Vt, Houston, Tex, St Louis, Mo, and Winnipeg, Manitoba, Canada

Abstract

Background

Asthma exacerbations are dangerous, expensive, and difficult to anticipate.

Objective

To characterize patients with asthma who had asthma episodes and exacerbations during 4 weeks of observation.

Methods

A total of 2032 volunteers with asthma (age, 3-64 years; 62% female subjects) were studied over two 2-week intervals after flu vaccine and placebo. Baseline data, including several asthma questionnaires, were analyzed for prediction of subsequent asthma events as recorded on diaries detailing peak flow, medication use, and health care use.

Results

During 28 days of diary collection, 43.2% of participants had at least 1 episode of poor asthma control. Most episodes were characterized by increased use of rescue medications or reductions in peak flow, but nearly 15% of participants had exacerbations characterized by use of systemic corticosteroids, unscheduled health care visits, or both. Episode frequency was highest in children <10 years of age. Additional risk factors were smoking, African American ethnicity, low lung function, and past history of severe asthma. The best predictors were symptom questionnaires, and a simple questionnaire concerning the preceding 2 weeks worked as well as more complex questionnaires or those reflecting longer periods. In regression analyses, questionnaire results, smoking, lung function, ethnicity, and asthma history all were associated with asthma episodes in people older than 10 years, whereas only asthma history was predictive in those <10 years.

Conclusion

Symptom questionnaires are predictive of subsequent asthma episodes in people older than age 10 years, but not in younger people.

Clinical implications

Simple assessments may be helpful in identifying patients most at risk for future asthma episodes.

Le texte complet de cet article est disponible en PDF.

Key words : Asthma exacerbations, asthma symptom questionnaires, asthma control

Abbreviations used : AS-2, AS-52, ASUI, BMI, EPAC, GINA, GINAMED, ICS, IRA, OCS, RR


Plan


 Supported by the American Lung Association.
Disclosure of potential conflict of interest: K. McCoy has received grant support from Chiron and Inspire Pharmaceuticals. C. G. Irvin has consulting arrangements with Biogen, MethaPharm, Merck, and Sepracor; has received grant support from GlaxoSmithKline; and is on the speakers’ bureau for Merck. J. G. Mastronarde has received grant support from Pfizer and is on the speaker’s bureau for GlaxoSmithKline. N. A. Hanania has received grant support from GlaxoSmithKline and Sepracor and is on the speakers’ bureau for GlaxoSmithKline and Genentech. N. R. Anthonisen has served on advisory boards for GlaxoSmithKline and Altana and has received honoraria from GlaxoSmithKline. The rest of the authors have declared that they have no conflict of interest.


© 2006  American Academy of Allergy, Asthma and Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 118 - N° 6

P. 1226-1233 - décembre 2006 Retour au numéro
Article précédent Article précédent
  • Biologic immune modifiers: Trials and tribulations—are we there yet?
| Article suivant Article suivant
  • Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide
  • Anne M. Fitzpatrick, Benjamin M. Gaston, Serpil C. Erzurum, W. Gerald Teague, for the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.